07:00 , Sep 2, 2013 |  BC Week In Review  |  Company News

Bever Pharmaceutical Pte. Ltd., Pharmstandard deal

Pharmstandard completed the acquisition of Bever for $590 million comprised of $542 million in global depositary receipts (GDRs) and $48 million in cash. Pharmstandard expects to include Bever in the branded OTC business, which Pharmstandard...
07:00 , Aug 19, 2013 |  BC Week In Review  |  Company News

Bever Pharmaceutical Pte. Ltd., Pharmstandard deal

Pharmstandard said it has agreed to acquire Bever for $590 million comprised of $542 million in global depositary receipts (GDRs) and $48 million in cash. The acquisition is subject to shareholder approval at an extraordinary...
07:00 , Jul 22, 2013 |  BC Week In Review  |  Company News

Pharmstandard pharmaceuticals news

Pharmstandard said its board plans to spin off the company's branded OTC business. Pharmstandard reported 2012 net revenue of RUB12.7 billion ($416.6 million) from the OTC business, which represented 25% of Pharmstandard's 2012 net revenue...